Next Article in Journal
Potent Cytotoxic Analogs of Amphidinolides from the Atlantic Octocoral Stragulum bicolor
Next Article in Special Issue
5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis
Previous Article in Journal
Cytotoxic Nitrogenous Terpenoids from Two South China Sea Nudibranchs Phyllidiella pustulosa, Phyllidia coelestis, and Their Sponge-Prey Acanthella cavernosa
Previous Article in Special Issue
Bromopyrrole Alkaloids from the Sponge Agelas kosrae
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clerodane Diterpenes from the Marine Sponge Raspailia bouryesnaultae Collected in South Brazil

by
Cintia Lhullier
1,*,†,
Eliane de Oliveira Tabalipa
1,†,
Fernanda Nienkötter Sardá
1,
Louis Pergaud Sandjo
2,
Naira Fernanda Zanchett Schneider
3,
João Luis Carraro
4,
Cláudia Maria Oliveira Simões
3 and
Eloir Paulo Schenkel
1
1
Laboratório de Produtos Naturais, Departamento de Ciências Farmacêuticas, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, Brazil
2
Laboratório de Farmacognosia, Departamento de Ciências Farmacêuticas, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, Brazil
3
Laboratório de Virologia Aplicada, Departamento de Ciências Farmacêuticas, Universidade Federal de Santa Catarina, Florianópolis 88040-900, SC, Brazil
4
Departamento de Invertebrados, Museu Nacional, Universidade Federal do Rio de Janeiro, Rio de Janeiro 20940-040, RJ, Brazil
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2019, 17(1), 57; https://doi.org/10.3390/md17010057
Submission received: 17 December 2018 / Revised: 31 December 2018 / Accepted: 12 January 2019 / Published: 16 January 2019
(This article belongs to the Special Issue Bioactive Compounds from Marine Sponges)

Abstract

:
The marine sponge Raspailia bouryesnaultae, collected in South Brazil, was selected for detailed investigation considering the results of a screening that pointed to an in vitro antiproliferative effect against non-small cells of human lung cancer (A549) and anti-herpes activity against Herpes Simplex virus type 1 (KOS and 29R strains) of ethanolic extracts. The fractionation and chemical investigation of the sponge’s hexanic fraction led to the isolation and structural elucidation of six clerodane diterpenes. The main component was identified as the already-reported raspailol (1), isolated from a sponge of the same genus collected in New Zealand. The structure of a new diterpene (2) with a rearranged skeleton was established by high-resolution mass spectrometry (HRMS) and 1D and 2D Nuclear magnetic resonance spectroscopy (NMR) experiments, and named here as raspadiene. Furthermore, four diterpenes were elucidated as isomers of clerodane diterpenes previously obtained from plants, namely kerlinic acid (3), kerlinic acid methyl ester (4), annonene (5), and 6-hydroxyannonene (6). They differ in their stereochemistry, since these diterpenes are characterized by a trans ring fusion at the decalin moiety and the relative configuration of the two methyl groups at C-8 and C-9 in a cis relationship (type trans/cis). The Raspailia diterpenes have a cis ring fusion at the decalin moiety, and the two methyl groups at C-8 and C-9 are in a trans relationship (type cis/trans). The isolated compounds were evaluated for their potential antiproliferative effects on human cancer cell line A549, and it was observed that the diterpenes bearing a hydroxyl group at C-6 exhibited moderate cytotoxic activity, with 50% inhibitory concentration (IC50) values lower than 25 μM. The evaluation of the potential anti-herpes activity against Herpes Simplex Virus type 1 (HSV-1, KOS and 29R strains) showed that the more promising results were observed for the new compound 2, since it inhibited HSV-1 (KOS and 29R strains) replication by 83% and 74%, respectively.

Graphical Abstract

1. Introduction

Sponges (phylum Porifera) are primitive filter-feeders, and although about 9000 species have already been described, it is thought that there are more than 20,000 marine sponges. They can produce high levels of cytotoxic compounds, with the majority coming from the secondary metabolism, protecting them against predation, overgrowth by fouling organisms, and/or competition for space [1]. It was proved that marine sponges produce an enormous array of antitumor, antiviral, anti-inflammatory, immunosuppressive, antibiotic, and other bioactive molecules that have potential for therapeutic use. Many bioactive metabolites from sponges proved to be inhibitors of certain enzymes, which often mediate or produce mediators of intracellular or intercellular messengers involved in disease pathogenesis [2,3,4].
The genus Raspailia contains more than 100 described species. These species are distributed world-wide, mainly in shallow waters [5]. Nowadays, over forty different secondary metabolites have been reported from Raspailia sponges, belonging to five main families of compounds: Raspailynes, raspailols, asmarines, agminosides, and clerodane diterpenes [6]. The seven compounds isolated in this work, from marine sponge Raspailia bouryesnaultae, belong to the class diterpenes of clerodane type.
Clerodane diterpenes are a large group of naturally occurring secondary metabolites found in hundreds of plant species from various families and described in a few marine sources, like sponges belonging to the genus Agelas [7], and especially to the genus Raspailia, such as the compounds raspailol [8], raspailenones A and B, raspailodanes A–G, and topsentanes A–B described for Raspailia topsenti [9]. During the last 25 years, more than 1300 diterpenoids and norditerpenoids with the clerodane carbon skeleton have been isolated, and recently, Li and co-workers proposed a classification comprising seven types of molecules based on this basic skeleton [7].
The Brazilian shallow-water sponge species Raspailia bouryesnaultae, class Demospongiae, is a recently re-described species [10]. In the literature, no chemical studies were found for this species. On the other hand, a cytotoxic activity was reported for the organic extract of the sponge Raspailia elegans (currently Raspailia bouryesnaultae) [11]. Therefore, in this report we describe the isolation and structure elucidation of one new compound (2) and five other diterpenes (1, 36), and the assessment of the in vitro activity of compounds 1 and 2 against Herpes simplex virus type 1, KOS and 29R strains.

2. Results and Discussion

2.1. Chemistry

Specimens of sponge Raspailia bouryesnaultae collected in the Coral and Aranhas Islands were extracted by maceration with ethanol. The extracts were concentrated under reduced pressure, and the resulting dried extract was suspended in distilled water and partitioned three times with n-hexane.
The hexane fractions were subsequently subjected to a series of chromatographic separations, resulting in the isolation of compounds 16 (Figure 1). Both collections contained identical compounds, but in different ratios. The major component was 1 in both extracts. All compounds were isolated as colorless oils.
Compound 1—The molecular formula was deduced as C20H28O4 by the NMR data and by the high-resolution mass spectrum that showed a pseudo-molecular ion peak [M + Na]+ at m/z = 355.1878 (calculated m/z 355.1880). Detailed analysis of the 1H and 13C NMR data, as shown in Table 1; Table 2, revealed the following substructures: A β-monosubstituted furan ring indicated by characteristic 1H NMR resonances at δH 7.33, 7.18, and 6.27 and the 13C NMR resonances at δC 142.6, 138.3, and 111.1; an olefinic methine (δH 5.76 and δC 120.7); a carbinol methine (δH 3.84 and δC 74.6); an acetal methine resonance at δH 5.64 and δC 99.6, and an oxygenated methylene at δC 68.7 (δH 4.38 and 4.48, J = 11.7 Hz). A methyl singlet could be observed at δH 0.95 and δC 25.3, and a methyl doublet at δH 0.91 (J = 6.8 Hz)/δC 15.7. The presence of only two methyl groups and a further five methylene groups suggested the structure of a diterpene containing a decalin moiety, bounded by two methylene groups to the monosubstituted furan ring, as commonly observed in diterpenes [7]. Considering the seven double-bond equivalents, an additional ring was deduced by the presence of an acetal methine resonance and an oxygenated methylene. These data pointed to the structure of a previously described clerodane diterpene, isolated from a sponge of the same genus (Raspailia sp.) collected and studied in New Zealand [8], named raspailol (Figure 1). Careful comparison of the reported spectral data confirmed this structure, which is characterized by the presence of a 5:10 cis ring junction at the decalin moiety, and also by the relative stereochemistry at C-8 and C-9, with the two methyl groups in a trans relationship, therefore classified as clerodane of the type cis/trans [7].
Compound 2—The molecular formula was deduced from the NMR spectral data and the high resolution mass spectrum as C21H30O3 (molecular peak [M + H]+ at m/z 331.2272; calculated 331.2268), pointing to seven degrees of unsaturation. The 13C NMR spectrum showed 21 carbon signals, as shown in Table 1 and Figure S3, including five quaternary carbons, six methylene groups, six methine groups, and four methyl groups, which were assigned by a HSQC/DEPT spectrum (Figure S3 in Supplementary Materials). The presence of a β-monosubstituted furan ring was indicated by the characteristic 1H NMR resonances at δH 7.34, 7.18, and 6.27 and the corresponding 13C NMR resonances at δC 142.7 (C-15), 138.4 (C-16) and 110.9 (C-14). HMBC and COSY experiments revealed the attachment of two methylene groups (C-12, δC 20.5; C-11, δC35.1) to the furan ring at the substituted carbon (C-13, δC 125.8) [9]. The comparison of the spectroscopic data (1H and 13C NMR) of 2 with compound 1 (raspailol) pointed to the absences of the acetal methine resonance (at δC 99.6), the oxygenated methylene (at δC 68.7), and the carbinol methine resonance at δH 3.84 (H-6, δC 74.6). Instead, the spectra clearly showed the presence of an exocyclic methylene, indicated by the resonances in δH 5.14 and 4.82 with corresponding carbons at δC 112.3 and δC 145.9 (quaternary), and also the presence of an oxygenated carbon as an ester group, as indicated by the 13C NMR signal at δC 174.6, and the IR absorption bands 1739 cm−1. These data suggested that in the main compound of the extract raspailol, the C-19 hemiacetal ring was opened, forming the exocyclic methylene group bounded to ring A, with bond rupture between C-5 and C-6. In this process, the carbinol subunit of (1) was oxidized and esterified, resulting in the carboxymethyl group at position 6. The opening of the hemiacetal ring in the structure of raspailol was already pointed out by the authors that reported its first isolation, where they mentioned the probable reversible ring opening of the hemiacetal ring to an aldehyde [8]. This new rearranged skeleton could be confirmed by the detailed observation of the HMBC correlation corresponding to ring A, between the hydrogens at δH 5.14 and 4.82 with the quaternary carbons in δC 133.8 (C-4), and between the methyl group singlet in δH 1.83 (H–C-18) with the quaternary carbons in δC 133.8 (C-4) and 154.9 (C-5). The other atoms of the former ring B (C-7, C-8, and C-9), as well the quaternary (C-20) and tertiary (C-17) methyl groups, could be located in this new structure by the HMBC correlations, according to Figure 2. The relative configurations at C-8 and C-9 were assumed to be the same as in raspailol, as this part of the moiety was not affected by the bond rupture between C-5 and C-6. Based on the above-mentioned data, metabolite 2 was identified as a new clerodane derivative, named here as raspadiene, possessing the structure proved to be as shown in Figure 2.
Compound 3—The high-resolution mass spectrum displayed the pseudo-molecular peak at m/z = 333.2029 ([M + H]+), indicating the molecular formula C20H28O4, which corresponds to seven double-bond equivalents. The NMR spectroscopic features of 3, given in Table 1 and Table 2, showed close resemblance with those of raspailol (compound 1), disclosing the presence of a β-monosubstituted furan ring, an olefinic methine identified by NMR resonances δH 5.88 with corresponding carbon at δC 129.1 (C-3), and a carbinol signal (1H NMR at δH 3.86 with corresponding carbon at δC 75.3). As in compound 2, it was also observed that the acetal methine resonance (at δC 99.6) and the oxygenated methylene (at δC 68.7) were absent, and the presence of a carboxylic acid was deduced by 1H NMR and 13C NMR resonances (δH 9.51 and δC 186.8). These resonances were in coherence with IR absorption bands at 1680 and 1180 cm−1, and a large absorption band over 3000 cm−1, as expected for carboxylic acids. One quaternary methyl group at δH 0.87/δC 21.3, one tertiary methyl group at δH 0.91/δC 15.6, and another methyl group at δH 1.88/δC15.6 were located, as in raspailol, at C-9, C-8, and C-4, and corresponded to C-20, C-17, and C-18. Comparison of spectroscopic data of compound 3 with those of previously reported clerodane diterpenes showed similar structural features to kerlinic acid, a substance isolated from the plant species Salvia keerlii [12]. Both compounds have the same molecular formula and substituents, but compound 3 is characterized by the cis ring fusion at the decalin moiety. Kerlinic acid also differs from compound 3 in the relative stereochemistry at C-8 and C-9, presenting the two methyl groups in a cis relationship. The 13C NMR chemical shifts have been used to distinguish between the relative configurations of the trans or cis junctions of the fused rings, and also their relative configurations at C-8 and C-9 [8,9,13]. The detailed comparison of the 13C NMR spectral data revealed similarities for the most resonances signals, but significant differences in the values for C-5 (δC 59.4 in compound 3 and δC 53.7 in kerlinic acid), C-10 (δC 43.7 in compound 3 and δC 48.4 in kerlinic acid), and for C-20 (δC 21.3 in compound 3 and δC 15.1 in kerlinic acid). These differences can be explained by the different stereochemistry, for example, the C-20 in kerlinic acid resonances at δC 15.1, being more protected due to the relative cis-cis position between the methyl groups at C-8 and C-9. For compound 3, the expected relative configuration of the methyl groups at C-8 and C-9 is trans, as indicated by the spectral data, and also according to the configuration of all other diterpenes clerodanes reported until now for the genus Raspailia sp. [8,9].
Compound 4—The molecular formula C21H30O4 was deduced from the HRMS and NMR data. The high-resolution mass spectrum showed a molecular ion peak [M + Na]+ at m/z 369.2035. The elemental composition accounted for seven double-bond equivalents. The 1H and 13C NMR data were very similar to that of compound 3, except for the resonances corresponding to a carboxylic acid group (δH 9.51 and δC 186.8) that were not observed. The presence of a methyl ester group was deduced by the resonance at δC 178.5, with the methoxyl singlet resonating at δH 3.50 and corresponding carbon at δC 52.0. The position of the ester group at C-19 was established by correlation in HMBC experiments. Therefore, the structure (Figure 1) was deduced as the methyl ester of compound 3, and it is not possible to exclude that it is an artefact, as methanol was used in the purification process by column chromatography on SephadexR.
Compound 5—The molecular formula C20H30O was deduced from the Electron Impact Mass Spectrum (EIMS) and NMR data, indicating six degrees of unsaturation. The mass spectrum exhibited a weak radical ion peak [M]+ at m/z 286 (Figure S22). The 13C NMR spectrum and the DEPT experiments revealed the presence of 20 carbon atoms, corresponding to four quaternary carbons, six methines, six methylenes, and four methyl groups. The NMR spectroscopy, given in Table 1 and Table 2, showed close resemblance with those of metabolites 3 and 4, disclosing the presence of the same β-monosubstituted furan ring and an olefinic methine. The 1H NMR spectrum further included four methyl groups at δH 1.98, 1.55, 1.07, and 0.81 and corresponding carbons at δC 20.1, 37.8, 26.0, and 15.3, which were located at C-18, C-19, C-20, and C-17, respectively. All the positions were confirmed by the 1H-1H-COSY and HMBC experiments (Figures S27 and S28). By consulting the available literature about clerodane diterpenes, it was verified that the 1H and 13C NMR data of compound 5 were similar to those of annonene, a diterpene previously isolated from Annona coriacea [14]. The observed fragmentation in the EIMS, as shown in Figure 3, is in accordance with this deduced structure. However, in annonene, as in the previously discussed kerlinic acid, rings A and B are trans fused, and the methyl groups at C-17 and C-20 have a cis relationship. Here in compound 5, the atoms connected to the C-5 and C-10 carbons, at the junction of the decalinic ring, assume a cis position, and the C-17 and C-20 methyl groups are in the trans position, as with compounds 1, 2, 3, and 4, and also according to the stereochemistry reported for the other clerodane diterpenes isolated for the genus Raspailia sp. [8,9].
Compound 6—The high-resolution mass spectrum allowed us to establish the molecular formula C20H30O2. The mass spectrum exhibited molecular ion peaks [M + H]+ at m/z 303.2317 (calculated 303.2319). The molecular formula indicates six degrees of unsaturation. The NMR spectroscopic data of 6, given in Table 1 and Table 2, showed close resemblance with those of compound 5. The main difference was an additional signal corresponding to a carbinol (δH 3.98, with corresponding carbon at δC 75.7). The location of the additional hydroxyl group was established considering the correlations of H–C-6 in the HMBC experiments with the quaternary carbon at δC 47.1 (C-5). By comparing the data obtained with the literature, it was verified that compound 6 has the same molecular formula and substituents as 6-hydroxyannonene, a clerodane diterpene first isolated from Croton sonderianus [15], which is characterized by the trans ring fusion at the decalin moiety, and presenting the two methyl groups at C-8 and C-9 in a cis relationship. As in compounds 1, 2, 3, and 4, the observed NMR data for compound 6 pointed to the cis ring fusion at the decalin moiety and the trans position of the methyl groups at C-17 and C-20, which is also in accordance with the stereochemistry reported for the other clerodane diterpenes isolated for the genus Raspailia sp. [8,9].

2.2. Antiproliferative Effects

A preliminary screening of the potential antiproliferative effects on human lung cancer A549 cells performed with the ethanolic extracts and hexane fractions of Raspailia bouryesnaultae, collected in the Coral and Aranhas Islands, showed that the hexane fraction from the Coral Island exhibited weak activity, with a 50% inhibitory concentration (IC50) value of 219.2 μg/mL, and the hexane fraction from the Aranhas Island presented medium activity, with an IC50 value of 89.3 μg/mL.
Compounds 16 were screened for their potential antiproliferative effects on human lung cancer cell line A549 and the non-tumor Vero cell line to estimate their selectivity. The results of the cytotoxicity assessment of the tested compounds after 48 h of incubation are given in Table 3. The lowest activity against A549 cells was observed for compound 5, which consists of the clerodane diterpene skeleton without any functional groups. The activity increased when functional groups were introduced to this basic skeleton, and compounds 1, 4, and 6, bearing a hydroxyl group at C-6, exhibited moderate cytotoxic activity, with IC50 values lower than 25 μM. Compounds 1 and 4 were the most selective for the cancer cell line over the non-tumor cell line.
Clerodane diterpenes have been largely investigated concerning their cytotoxic activity. The extensive review of Li and collaborators [7] described a variety of clerodane derivatives with cytotoxic activity against many cancer cell lines. Other clerodanes with similar stereochemistry (considering the 5:10 cis junction of the fused rings of the decalin moiety and the relative stereochemistry at C-8 and C-9) were reported to be active in the 1–10 µM range. However, these more active clerodanes presented an unsaturated open side chain at C-9, instead of the furanyl ethyl side chain as in the compound reported here [16,17].

2.3. Anti-Herpes Activity

Compounds 16 were also screened for their potential anti-herpes activity against Herpes Simplex Virus type 1 (HSV-1, KOS and 29R strains, sensitive and resistant to acyclovir, respectively). The results indicated that compounds 2 and 4 inhibited viral HSV-1 (KOS strain) replication by 83% and 50%, respectively, and compound 2 also inhibited HSV-1 (29R strain) replication by more than 70%. The other compounds did not present significant inhibition of virus replication (<50%). The results are show in Table 4.
In view of these results, compounds 2 and 4 were further assayed to determine their IC50 and selective index (SI) values. The results showed that compound 2 demonstrated the best activity, with SI values >3.0 for both tested strains. These results are given in Table 5.
Both active compounds (2 and 4) possessed a carboxymethyl ester group, whereas the other ones (1 and 3) without this specific group displayed weak activity or were not active. The possible structure–activity relationships remain to be investigated based on a higher extensive panel of compounds.

3. Materials and Methods

3.1. General

Infrared spectra (IR) were obtained in an IR Prestige-21 FTIR-8400 S (Shimadzu, Tokyo, Japan) using KBr. UV spectra were obtained on a UV/Vis lambda 15 spectrophotometer (Perkin-Elmer, Waltham, MA, USA)) using ethanol. NMR spectra were obtained on a Bruker Fourier 300 (1H: 300 MHz, 13C: 75 MHz) and DRX-400 (1H: 400 MHz, 13C: 100 MHz) in CDCl3. Chemical shifts were given in δ (ppm), using tetramethylsilane (TMS) as an internal standard. The 2D experiments (HSQC, HMBC, 1H-1H COSY, NOESY) were performed using standard Bruker pulse sequences. Low-resolution Electron Impact mass spectra were recorded on a Gas chromatography–mass spectrometry system, consisting of a Perkin-Elmer GC Clarus 680® coupled to a Clarus SQ8 mass spectrometer with a quadrupole detector (scan range 55–550 Da), using an Elite-5mS non-polar silica capillary column (30 m, 0.25 mm i.d., 0.25 μm film thickness). The samples (1 µL) were introduced via an all-glass injector working in the split mode (5.0 mL min−1), with helium (99.999% purity) as a carrier gas at a flow rate of 1 mL min−1. The ion source temperature was 180 °C, and the GC inlet and transfer line to the ion source were both held at 250 °C.
High-resolution mass spectra were recorded by direct sample injection on a mass spectrometer Waters® Xevo G2-S QTof (Waters, Milford, MA, USA) equipped with an electrospray (ESI) probe which can operate in positive and negative mode ionization. ESI positive mode ionization was used with capillary voltage of 2 kV. The temperatures of the cone and desolvation were set at 80 and 120 °C, respectively. N2 flows to control the temperatures of the cone and the desolvation were 100 and 400 L/h, respectively. Leucine encephalin was the lockspray reference sample, with reference mass value at m/z 556.2771.
During the isolation procedures, chromatographic separations were performed using a medium-pressure liquid chromatography system (Syncore®/Büchi, Buchi, New Castle, DE, USA)) and gravity column chromatography on silica gel 60 (0.040–0.063 mm, Vetec®, St. Louis, MO, USA)). Thin Layer Chromatography analysis was performed on silica gel F254 plates (Macherey-Nagel®, Düren, Germany)), and spots were detected after spraying with anisaldehyde sulfuric reagent and heating at 100 °C for 1 min. HPLC separations were conducted using a Shimadzu HPLC System with LC-10AD pump and SPD-10A UV/vis, using a Luna C18 (Phenomenex®, Torrance, CA, USA, 250 cm × 10 mm, 10 µm) column.

3.2. Biological Material Collection

Specimens of Raspailia bouryesnaultae were collected by SCUBA at a depth of 10–12 m off the coast of Coral Island (27°54′28″S; 48°31′12″W) in May 2014, Garopaba, and off the coast of Aranhas Island (27°29′12″S; 48°21′37″W) in May 2016, Florianópolis, Santa Catarina State, South Brazil. The biological materials were kept frozen at −20 °C. Voucher specimens were identified by João Luis Carraro, and were deposited at the Sponge Collection of the Departamento de Invertebradostes (Universidade Federal de Rio de Janeiro, Rio de Janeiro, RJ, Brazil).

3.3. Extraction and Isolation

The frozen specimens of sponge from Coral Island (2.0 kg) were extracted three times with ethanol, for seven days each time. The joined extracts were concentrated under reduced pressure. The resulting dried extract (6.5 g) was suspended in distilled water and partitioned three times with n-hexane, resulting in 3.3 g of n-hexane fraction (HF fraction). The HF fraction was subjected to a medium-pressure liquid chromatographic column on silica gel (hexane-ethyl acetate-methanol gradient) to afford 20 fractions (A–T). Fractions FC, FH, and FP yielded compound 2 (3.5 mg), compound 4 (7.3 mg), and compound 1 (32.7 mg), respectively. Fractions FF, FG, and FJ (128 mg) were purified by reverse-phase HPLC, using MeOH as an eluent, to afford compounds 4 (22 mg) and 6 (6.4 mg). Fractions FB and FE (484 mg) were combined and further fractionated by gravity column chromatography on silica gel, using cyclohexane with increasing amounts of EtOAc as the mobile phase, to yield 12 fractions (E1–E12). Fractions E3 and E5 (35 mg) were purified by reverse-phase HPLC, using MeOH:H2O (9:1) as an eluent, to afford compound 2 (6.6 mg). Fraction FI (7.9 mg) was purified by reverse-phase HPLC, using MeOH as an eluent, to afford compound 3 (3.2 mg).
The frozen specimens of sponge from Aranhas Island (2.0 kg) were extracted three times with ethanol, for seven days each time. The joined extracts were concentrated under reduced pressure. The resulting dried extract (6.5 g) was suspended in distilled water and partitioned three times with n-hexane, resulting in 3.3 g (HF fraction). The HF fraction was subjected to a medium-pressure liquid chromatographic column on silica gel (hexane-ethyl acetate-methanol gradient) to afford 17 fractions (A–Q). Fraction FB yielded compound 5 (5.7 mg). Fraction FM yielded compound 1 (17.6 mg). Fractions FH, FJ, and FL (69.3 mg) were purified by reverse-phase HPLC, using MeOH as an eluent, to afford compounds 4 (6.3 mg) and 3 (2.9 mg). Fractions FC, FE, and FF (194.5 mg) were combined and further fractionated by gravity column chromatography on silica gel, using cyclohexane with increasing amounts of EtOAc as the mobile phase, to yield 10 fractions (E1–E10). Fractions E3, E4, and E5 (15 mg) were purified by reverse-phase HPLC, using MeOH:H2O (9:1) as an eluent, to afford compound 2 (2.5 mg).
Compound 1 (raspailol): Colorless oil, HRMS [M + Na]+ m/z = 355.1878 (calculated for C20H28O4 = 355.1880). NMR: Table 1 and Table 2 and Supplementary Information.
Compound 2 (raspadiene): Colorless oil, IR (KBr) υ cm−1: 2910, 1735, 1620, 1440, 1285, 1140, 1015. HRMS m/z: 331.2272 [M + H]+ (calculated for C21H31O3 = 331.2268). NMR: Table 1 and Table 2 and Supplementary Information.
Compound 3: Colorless oil, IR (KBr) υ cm−1: 3520, 2910, 2380, 1680, 1540, 1510, 1180, 880, 620. HRMS m/z: 333.2029 [M + H]+ (calculated for C20H29O4: m/z = 333.2060). NMR: Table 1 and Table 2 and Supplementary Information.
Compound 4: Colorless oil, IR (KBr) υ cm−1: 3510, 2920, 1740, 1680, 1560, 1240, 1180, 1080, 1060, 870. HRMS m/z: 369.2035 [M + Na]+ (calculated for C21H30O4Na = 369.2036). NMR: Table 1 and Table 2 and Supplementary Information.
Compound 5: Colorless oil, IR (KBr) υ cm−1: 3420, 1640, 1580, 1540. EIMS (70 eV): 286 (M, 5%), 207 (100%), 191 (20%), 107 (12%), 95 (31%), 81 (35%) NMR: Table 1 and Table 2 and Supplementary Information.
Compound 6: Colorless oil, IR (KBr) υ cm−1: 3510, 1620, 1440, 1380, 620. HRMS m/z: 303.2317 [M + H]+ (calculated for C20H31O2 = 303.2319). NMR: Table 1 and Table 2 and Supplementary Information.

3.4. Antiproliferative Assays

Non-small cells of human lung cancer cells (A549; ATCC: CCL 195) and African Green monkey kidney fibroblasts (Vero; ATCC: CCL81) were grown in Eagle’s minimum essential medium (MEM; Cultilab, Campinas, Brazil) supplemented with 1% glutamine (Gibco, Carlsbad, CA, USA) and 10% fetal bovine serum (FBS; Gibco, Carlsbad, CA, USA), and maintained at 37 °C and 5% CO2 in a humidified atmosphere. The antiproliferative screening was performed by sulforhodamine B assay (SRB) [18]. In summary, A549 cells were seeded into 96-well plates (2.5 × 104 cells per well) and exposed to different concentrations of compounds 16 for 48 h. Paclitaxel (PAC, Sigma-Aldrich, St. Louis, MO, USA) was used as a positive control. After incubation, 10% trichloroacetic acid (TCA) was added to each well to fix the cells, and then the cells were washed and stained with SRB. The protein-bound dye was dissolved in 10 mM Tris-Base [(tris(hydroxymethyl) aminomethane] solution, and the optical densities (OD) were read at 510 nm on a Spectra Max M2 spectrophotometer (Molecular Devices, Molecular Devices, San Jose, CA, USA). The 50% inhibitory concentration (IC50) of each compound was defined as the concentration that inhibited cell viability by 50% when compared to untreated controls. Vero cells were seeded into 96-well plates (2.5 × 104 cells per well) to determine, also by SRB assay, the CC50 of each compound, which is defined as the concentration that reduced non-tumor cell viability by 50% when compared to untreated controls. The ratio between CC50 and IC50 values was calculated to obtain the selectivity index (SI) of each sample.

3.5. Anti-Herpes Assays

Firstly, the cytotoxicity of compounds 16 was determined by SRB assay as described above. HSV-1 (KOS and 29R strains, which are sensitive and resistant to acyclovir, respectively, Faculty of Pharmacy, University of Rennes I, Rennes, France) were propagated in the permissive Vero cells. Viral stocks were titrated as based on plaque-forming units (PFU), counted by plaque assay as previously described [19], and stored at −80 °C until used. To perform the anti-HSV-1 screening, the viral plaque number reduction assay was used as described previously by Boff et al. [20]. Briefly, confluent Vero cell monolayers (2.5 × 105 cells per well) were infected with approximately 100 PFU of each virus strain for 1 h at 37 °C. Treatments were performed by adding non-cytotoxic concentrations of the compounds after viral infection (post-infection treatment). Cells were then washed with phosphate-buffered saline (PBS) and overlaid with MEM containing 1.5% carboxymethylcellulose (CMC; Sigma-Aldrich) in the presence or absence of different concentrations of the compounds and incubated for 48 h. Cells were fixed and stained with naphthol blue-black (Sigma-Aldrich), and viral plaques were counted by using a stereomicroscope. The results were presented as percentages of viral inhibition or by IC50 values, which are defined as the concentration of each sample that inhibited viral plaque formation by 50% (IC50) when compared to untreated controls. The ratio between CC50 and IC50 values was calculated to obtain the selectivity index (SI) of each sample. Acyclovir (ACV, Sigma-Aldrich) was used as a positive control for HSV-1 (KOS strain) and as a negative control for HSV-1 (29-R strain) replication.

4. Conclusions

Chemical investigation of the sponge Raspailia bouryesnaultae collected from South Brazil led to the isolation and structural elucidation of raspailol as the main component, previously reported from a sponge of the same genus collected in New Zealand, and a new diterpene with a rearranged skeleton.
Furthermore, four diterpenes were elucidated as isomers of clerodane diterpenes previously isolated from plants, namely kerlinic acid, kerlinic acid methylester, annonene, and 6-hydroxyannonene. They differ in their stereochemistry, since these diterpenes are characterized by a trans ring fusion at the decalin moiety, and the relative configuration of the two methyl groups at C-8 and C-9 in a cis relationship type (trans/cis), whereas the Raspailia diterpenes have a cis ring fusion at the decalin moiety, and the two methyl groups at C-8 and C-9 are in a trans relationship (type cis/trans).
The isolated compounds displayed antiproliferative effects on human cancer cell line A549, exhibiting moderate cytotoxic activity, with IC50 values lower than 25 μM for the diterpenes bearing a hydroxyl group at C-6.
The evaluation of the potential anti-herpes activity (HSV-1, KOS and 29R strains, sensitive and resistant to acyclovir, respectively) showed that the more promising results were observed for the new compound 2, since it inhibited HSV-1 (KOS and 29R strains) replication by 83% and 74%, respectively.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/17/1/57/s1, Figure S1: High-resolution mass spectrum of compound 1, Figure S2: 1H NMR spectrum of compound 1 at 400 MHz in CDCl3, Figure S3: 13C NMR spectrum of compound 1 at 100 MHz in CDCl3, Figure S4: High-resolution mass spectrum of compound 2, Figure S5: 1H NMR spectrum of compound 2 at 400 MHz in CDCl3, Figure S6: 13C NMR spectrum of compound 2 at 100 MHz in CDCl3, Figure S7: DEPT 135 NMR spectrum of compound 2 at 100 MHz in CDCl3, Figure S8: HSQC NMR spectrum of compound 2 at 300 MHz in CDCl3, Figure S9: 1H-1H COSY NMR spectrum of compound 2 at 300 MHz in CDCl3, Figure S10: HMBC NMR spectrum of compound 2 at 300 MHz in CDCl3, Figure S11: High-resolution mass spectrum of compound 3, Figure S12: 1H NMR spectrum of compound 3 at 400 MHz in CDCl3, Figure S13: 13C NMR spectrum of compound 3 at 75 MHz in CDCl3, Figure S14: HSQC NMR spectrum of compound 3 at 300 MHz in CDCl3, Figure S15: High-resolution mass spectrum of compound 3, Figure S16: 1H NMR spectrum of compound 4 at 400 MHz in CDCl3, Figure S17: 13C NMR spectrum of compound 4 at 100 MHz in CDCl3, Figure S18: DEPT 135 NMR spectrum of compound 4 at 100 MHz in CDCl3, Figure S19: HSQC NMR spectrum of compound 4 at 300 MHz in CDCl3, Figure S20: 1H-1H COSY NMR spectrum of compound 4 at 300 MHz in CDCl3, Figure S21: HMBC NMR spectrum of compound 4 at 300 MHz in CDCl3, Figure S22: High-resolution mass spectrum of compound 5, Figure S23: 1H NMR spectrum of compound 5 at 400 MHz in CDCl3, Figure S24: 13C NMR spectrum of compound 5 at 100 MHz in CDCl3, Figure S25: DEPT 135 NMR spectrum of compound 5 at 100 MHz in CDCl3, Figure S26: HSQC NMR spectrum of compound 5 at 300 MHz in CDCl3, Figure S27: 1H-1H COSY NMR spectrum of compound 5 at 300 MHz in CDCl3, Figure S28: HMBC NMR spectrum of compound 5 at 300 MHz in CDCl3, Figure S29: High-resolution mass spectrum of compound 6, Figure S30: 1H NMR spectrum of compound 6 at 400 MHz in CDCl3, Figure S31: 13C NMR spectrum of compound 6 at 100MHz in CDCl3, Figure S32: HSQC NMR spectrum of compound 6 at 300 MHz in CDCl3, Figure S33: HMBC NMR spectrum of compound 6 at 300 MHz in CDCl3.

Author Contributions

C.L. and E.d.O.T. equally contributed to this work, and together with F.N.S. and N.F.Z.S. were responsible for planning and carrying out the experiments. J.L.C. was responsible for collecting and identifying the samples. L.P.S. contributed to the structural elucidation and the manuscript writing/editing. C.M.O.S. and E.P.S. contributed to the design and implementation of the research, the analyses of the results, and the manuscript writing/editing.

Funding

This research was funded by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, MCTI (Marine Biotechnology Network. Grant number 408934/2013-1)), the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, MEC, PNPD), and the Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC (Biodiversidade. Grant number 14170/2010)).

Acknowledgments

The authors are grateful to CNPq and CAPES for their research fellowships.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Perdicaris, S.; Vlachogianni, T.; Valavanidis, A. Bioactive natural substances from marine sponges: New developments and prospects for future pharmaceuticals. Nat. Prod. Chem. Res. 2013, 1, 1–8. [Google Scholar] [CrossRef]
  2. Sagar, S.; Kaur, M.; Minnerman, K.P. Antiviral lead compounds from marine sponges. Mar. Drugs 2010, 8, 2619–2638. [Google Scholar] [CrossRef] [PubMed]
  3. Vila, F.A.; Gerwick, L. Marine natural product drug discovery: Leads for treatment of inflammation.cancer.infections and neurological disorders. Immunopharmacol. Immunotoxicol. 2010, 32, 228–237. [Google Scholar] [CrossRef] [PubMed]
  4. Frota, M.J.; Silva, R.B.; Mothes, B.; Henriques, A.T.; Moreira, J.C. Current status on natural products with antitumor activity from Brazilian marine sponges. Curr. Pharm. Biotechnol. 2012, 13, 235–244. [Google Scholar] [CrossRef] [PubMed]
  5. Hooper, J.N.A.; Van Soest, R.W.M. SystemaPorifera: A Guide to the Classification of Sponges; Kluwer Academic/Plenum: New York, NY, USA, 2002. [Google Scholar]
  6. Northover, B.J. Natural Products Studies of Marine Organisms of the South Pacific. Master’s Thesis, Victoria University of Wellington, Wellington, New Zealand, 2012. [Google Scholar]
  7. Li, R.; Morris-Natschke, S.L.; Kuo-Hsiung, L. Clerodanediterpenes: Sources, structures, and biological activities. Nat. Prod. Rep. 2016, 33, 1166–1226. [Google Scholar] [CrossRef] [PubMed]
  8. West, L.M.; Northcote, P.T.; Battershill, C.N. Two New ClerodaneDiterpenes from the New Zealand Marine Sponge Raspailia sp. Aust. J. Chem. 1998, 51, 1097–1101. [Google Scholar] [CrossRef]
  9. Ryan., J.M. Novel Secondary Metabolites from New Zealand Marine Sponges. Ph.D. Thesis, Victoria University of Wellington, Wellington, New Zealand, 2007. [Google Scholar]
  10. Lerner, C.; Carraro, J.L.; Soest, R.V. Raspailia (Raspaxilla) bouryesnaultae, a new name for Brazilian Raspaxillaelegans Boury-Esnault, 1973 (Demospongiae, Poecilosclerida, Raspaileedae) with a redescription and a new record. Zootaxa 2006, 1129, 37–45. [Google Scholar]
  11. Rangel, M.; Sanctis, B.; Freitas, J.C.; Polatto, J.M.; Granato, A.C.; Berlinck, R.G.S.; Hajdu, E. Cytotocic and neurotoxic activities in extracts of marine sponges (Porifera) from southeastern Brazilian coast. J. Exp. Mar. Bio. Ecol. 2001, 262, 31–40. [Google Scholar] [CrossRef]
  12. Rodríguez-Hahn, L.; García, A.; Esquivel, B.; Cárdenas, J. Structure of kerlinic acid from Salvia keerlii. Chemical correlation with melisodoric acid. Can. J. Chem. 1987, 65, 2687–2690. [Google Scholar] [CrossRef]
  13. Zdero, C.; Bohlmann, F.; King, R.M. Diterpenes and Norditerpenes from the Aristeguetia Group. Phytochemistry 1991, 30, 2991–3000. [Google Scholar] [CrossRef]
  14. Ferrari, M.; Pelizzoni, F. New diterpenoids with clerodane skeleton. Pergamon 1971, 10, 3267–3269. [Google Scholar] [CrossRef]
  15. Silveira, E.R.; Mcchesney, J.D. 6,7-Oxygenated neo-clerodane furan diterpenes from Croton sonderianus. Phytochemistry 1994, 36, 1457–1463. [Google Scholar] [CrossRef]
  16. Itokawa, H.; Totsuka, N.; Morita, H.; Takeya, K.; Iitaka, Y.; Schenkel, E.P.; Motidome, M. New Antitumor Principles, Casearins A-F, for Casearia sylvestris Sw. (Flacourtiaceae). Chem. Pharm. Bull. 1990, 38, 3384–3388. [Google Scholar] [CrossRef] [PubMed]
  17. Morita, H.; Nakayama, M.; Kojima, H.; Takeya, K.; Itokawa, H.; Schenkel, E.P.; Motidome, M. Structures and Cytotoxic Activity Relationship of Casearins, New Clerodane Diterpenes from Casearia sylvestris SW. Chem. Pharm. Bull. 1991, 39, 693–697. [Google Scholar] [CrossRef] [PubMed]
  18. Vichai, V.; Kirtikara, K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 2006, 1, 1112–1116. [Google Scholar] [CrossRef] [PubMed]
  19. Burleson, F.G.; Chamberts, T.M.; Wiedbrauk, D.L. Virology: A Laboratory Manual; Academic, University of San Diego: San Diego, CA, USA, 1992. [Google Scholar]
  20. Boff, L.; Silva, I.T.; Argenta, D.F.; Farias, L.M.; Alvarenga, L.F.; Padua, R.M.; Braga, F.C.; Leite, J.P.; Kratz, J.M.; Simões, C.M.O. Strychnos pseudoquina A. St. Hil.: A Brazilian medicinal plant with promising in vitro anti-herpes activity. J. Appl. Microbiol. 2016, 121, 1519–1529. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structures of compounds 16.
Figure 1. Chemical structures of compounds 16.
Marinedrugs 17 00057 g001
Figure 2. Selected HMBC correlations observed for compound 2.
Figure 2. Selected HMBC correlations observed for compound 2.
Marinedrugs 17 00057 g002
Figure 3. The main fragments observed in the Electron Impact Mass Spectrum of compound 5.
Figure 3. The main fragments observed in the Electron Impact Mass Spectrum of compound 5.
Marinedrugs 17 00057 g003
Table 1. 13C NMR data of compounds 16 in CDCl3 (100 MHz; δ in ppm).
Table 1. 13C NMR data of compounds 16 in CDCl3 (100 MHz; δ in ppm).
Position123456
119.724.738.219.119.621.6
225.824.518.726.525.827.1
3120.7127.5129.1124.8122.4123.9
4139.1133.8136.2135.5148.0142.1
553.4145.959.454.638.247.1
674.6174.675.375.533.075.7
738.337.638.538.825.838.6
836.836.436.136.837.437.0
938.041.038.938.738.439.1
1040.445.443.744.444.643.5
1132.835.126.132.132.346.0
1218.920.518.718.918.919.4
13130.0125.8124.9125.7123.2124.4
14111.1110.9110.6110.9111.0111.0
15142.6142.7142.8142.7142.6142.7
16138.3138.4138.8138.3138.5138.5
1715.715.815.615.715.315.6
1868.720.423.422.820.122.7
1999.6112.3186.8178.537.818.1
2025.322.121.326.426.028.6
21-51.4-52.0--
Table 2. 1H NMR data of compounds 1–6 in CDCl3 (400 MHz; δ in ppm; J in Hz).
Table 2. 1H NMR data of compounds 1–6 in CDCl3 (400 MHz; δ in ppm; J in Hz).
Position123456
1.73 (m)2.35 (d, 1.83)1.76 (m)1.73 (m)1.70 (m)1.71 (m)
2.20 (m)2.11 (d, 1.83)1.48 (m)2.16 (m)1.95 (m)2.04 (m)
2.20 (m)2.35 (d, 1.83)1.75 (m)2.16 (m)2.00 (m)2.04 (m)
35.76 (m)5.63 (d, 2.8)5.88 (s)5.64 (s)5.35 (s)5.50 (s)
3.84 (m)-3.86 (m)3.87 (td, 11.8, 4.7)1.21 (m)3.98 (m)
----1.24 (s)-
1.48 (m)2.08 (m)1.62 (m)1.62 (m)1.95 (m)1.56 (m)
1.65 (m)2.57 (m)1.76 (m)1.73 (m)2.00 (m)1.75 (m)
81.81 (m)2.30 (m)1.76 (m)1.83 (m)1.51 (m)2.16 (m)
102.00 (dd, 13.2, 3.1)2.47 (m)2.16 (m)2.36 (m)1.43 (m)2.20 (d, 7.8)
11α1.40 (m)1.60 (m)2.07 (m)1.26 (m)1.49 (m)1.83 (m)
11β1.56 (m)1.65 (m)2.17 (m)1.52 (m)1.61 (m)2.09 (m)
12α2.18 (m)1.83 (d, 1.51)2.19 (m)2.36 (m)2.35 (m)2.52 (m)
12β2.61 (td, 12.9, 3.3)2.35 (d, 1.51)2.39 (m)2.45 (m)2.45 (m)2.52 (m)
146.27 (s)6.24 (s)6.25 (s)6.27 (s)6.28 (s)6.27 (s)
157.33 (t, 1.6)7.34 (t, 1.6)7.36 (t, 1.5)7.35 (t, 1.6)7.35 (s)7.35 (t, 1.6)
167.18 (s)7.18 (s)7.22 (s)7.19 (s)7.21 (s)7.21 (s)
170.91 (d, 6.8)0.91 (s)0.91 (d, 6.8)0.88 (d, 6.5)0.81 (d, 6.8)0.85 (d, 6.9)
18α4.34 (dq, 11.7, 1.9)1.83 (s)1.80 (s)1.76 (s)1.98 (s)1.88 (m)
18β4.48 (m)-----
19α5.64 (d, 2.6)4.82 (s)9.5 (d, 2.9)-1.55 (s)1.28 (s)
19β-5.14 (s)----
200.95 (s)0.96 (s)0.87 (s)0.97 (s)1.07 (s)1.03 (s)
21-3.87 (s)-3.50 (s)--
6OH2.92 (ls)--2.83 (ls)--
Table 3. Antiproliferative effects of compounds 16 on non-small cells of human lung cancer (A549) and Vero (healthy fibroblasts from kidneys of African Green monkeys) cell lines, after 48 h of treatment by sulforhodamine B assay.
Table 3. Antiproliferative effects of compounds 16 on non-small cells of human lung cancer (A549) and Vero (healthy fibroblasts from kidneys of African Green monkeys) cell lines, after 48 h of treatment by sulforhodamine B assay.
CompoundsIC50 µMCC50 µMSI
A549 Cell Line (Confidence Interval 95%)VERO Cell Line (Confidence Interval 95%)
124.12
(15.68 a 37.09)
148.3
(93.30 a 235.7)
6.14
2100.3
(43.54 a 231.2)
>2502.49
366.22
(49.16 a 89.21)
181.5
(140.7 a 234.2)
2.74
420.63
(11.64 a 36.55)
98.41
(74.08 a 130.7)
4.77
5143.7
(107.7 a 191.9)
>250>1.74
624.51
(17.72 a 33.89)
40.77
(27.74 a 59.91)
1.66
Data are presented as IC50 values (µM) and 95% confidence intervals obtained by non-linear regression. Data represent the mean of three independent experiments; CC50: cytotoxic concentration for 50% of cells; IC50: concentration that inhibited 50% of cell viability; SI: selective index = CC50/IC50.
Table 4. Percentages of HSV-1 (KOS strain and 29R strain) inhibition after 48 h of treatment with compounds 16 by viral plaque number reduction assay.
Table 4. Percentages of HSV-1 (KOS strain and 29R strain) inhibition after 48 h of treatment with compounds 16 by viral plaque number reduction assay.
CompoundsTested Concentration (µg/mL)% HSV-1 Inhibition ± SD
KOS Strain29R Strain
110034.56 ± 7.360
210083.41 ± 16.1274.21 ± 6.14
310024.42 ± 4.0432.03 ± 6.12
45050.23 ± 8.2414.45 ± 5.46
510015.20 ± 4.6530.85 ± 9.07
62500
Data represent the mean of three independent experiments ± SD.
Table 5. Anti-herpes activity [anti-HSV-1 (KOS and 29R strains)] after 48 h of treatment with compounds 2 and 4 by viral plaque number reduction assay.
Table 5. Anti-herpes activity [anti-HSV-1 (KOS and 29R strains)] after 48 h of treatment with compounds 2 and 4 by viral plaque number reduction assay.
CompoundsCC50IC50SI
Vero Cells(KOS Strain)(29R Strain)(KOS Strain)(29R Strain)
2>25081.39 ± 9.8274.93 ± 7.30>3.07>3.33
498.41
(74.08–130.7)
52.38 ± 4.78ND1.87-
HSV-1 = Herpes Simplex Virus type 1; Data represent the mean of three independent experiments; CC50: cytotoxic concentration for 50% of cells (95% Confidence Interval); IC50: concentration ± SD that inhibited 50% of viral replication; SI: selective index = CC50/IC50; ND: not determined.

Share and Cite

MDPI and ACS Style

Lhullier, C.; de Oliveira Tabalipa, E.; Nienkötter Sardá, F.; Sandjo, L.P.; Zanchett Schneider, N.F.; Carraro, J.L.; Oliveira Simões, C.M.; Schenkel, E.P. Clerodane Diterpenes from the Marine Sponge Raspailia bouryesnaultae Collected in South Brazil. Mar. Drugs 2019, 17, 57. https://doi.org/10.3390/md17010057

AMA Style

Lhullier C, de Oliveira Tabalipa E, Nienkötter Sardá F, Sandjo LP, Zanchett Schneider NF, Carraro JL, Oliveira Simões CM, Schenkel EP. Clerodane Diterpenes from the Marine Sponge Raspailia bouryesnaultae Collected in South Brazil. Marine Drugs. 2019; 17(1):57. https://doi.org/10.3390/md17010057

Chicago/Turabian Style

Lhullier, Cintia, Eliane de Oliveira Tabalipa, Fernanda Nienkötter Sardá, Louis Pergaud Sandjo, Naira Fernanda Zanchett Schneider, João Luis Carraro, Cláudia Maria Oliveira Simões, and Eloir Paulo Schenkel. 2019. "Clerodane Diterpenes from the Marine Sponge Raspailia bouryesnaultae Collected in South Brazil" Marine Drugs 17, no. 1: 57. https://doi.org/10.3390/md17010057

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop